The burgeoning landscape of therapeutic interventions for obesity disorders has witnessed considerable attention focused on GLP-3 receptor agonists and, more recently, the dual GIP and GLP-3 receptor agonist https://kalegmib231804.wonderkingwiki.com/2044191/glp_3_retatrutide_a_comparative_analysis